Loading...
Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial)
Background: The TROFEO trial demonstrated that febuxostat causes greater and more rapid reduction of serum uric acid (s-UA) than topiroxostat. We compared these drugs in patients with chronic kidney disease (CKD) by sub-analysis of the TROFEO trial. Methods: This sub-analysis targeted patients with...
Na minha lista:
| Udgivet i: | Ann Thorac Cardiovasc Surg |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435131/ https://ncbi.nlm.nih.gov/pubmed/31748427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5761/atcs.oa.19-00162 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|